Ardent Health Partners (ARDT) Stock Forecast, Price Target & Predictions
ARDT Stock Forecast
Ardent Health Partners stock forecast is as follows: an average price target of $23.00 (represents a 38.22% upside from ARDT’s last price of $16.64) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.
ARDT Price Target
The average price target for Ardent Health Partners (ARDT) is $23.00 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $27.00 to $20.00. This represents a potential 38.22% upside from ARDT's last price of $16.64.
ARDT Analyst Ratings
According to 7 Wall Street analysts, Ardent Health Partners's rating consensus is 'Buy'. The analyst rating breakdown for ARDT stock is 0 'Strong Buy' (0.00%), 6 'Buy' (85.71%), 1 'Hold' (14.29%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Ardent Health Partners Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 10, 2024 | Matthew Gillmor | KeyBanc | $24.00 | $18.12 | 32.45% | 44.23% |
| Sep 19, 2024 | Scott Fidel | Stephens | $24.00 | $17.21 | 39.45% | 44.23% |
| Aug 16, 2024 | Timothy Greaves | Loop Capital Markets | $21.00 | $16.97 | 23.75% | 26.20% |
| Aug 16, 2024 | David MacDonald | Truist Financial | $22.00 | $16.97 | 29.64% | 32.21% |
| Aug 12, 2024 | David MacDonald | Truist Financial | $21.00 | $15.64 | 34.27% | 26.20% |
| Aug 12, 2024 | Ann Hynes | Mizuho Securities | $20.00 | $15.64 | 27.88% | 20.19% |
| Aug 12, 2024 | Craig Hettenbach | Morgan Stanley | $27.00 | $15.64 | 72.63% | 62.26% |
The latest Ardent Health Partners stock forecast, released on Oct 10, 2024 by Matthew Gillmor from KeyBanc, set a price target of $24.00, which represents a 32.45% increase from the stock price at the time of the forecast ($18.12), and a 44.23% increase from ARDT last price ($16.64).
Ardent Health Partners Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 7 |
| Avg Price Target | - | $24.00 | $22.71 |
| Last Closing Price | $16.64 | $16.64 | $16.64 |
| Upside/Downside | -100.00% | 44.23% | 36.48% |
In the current month, the average price target of Ardent Health Partners stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Ardent Health Partners's last price of $16.64. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 06, 2024 | Bank of America Securities | - | Neutral | Downgrade |
| Oct 10, 2024 | KeyBanc | - | Overweight | Initialise |
| Sep 19, 2024 | Stephens | Overweight | Overweight | Hold |
| Aug 16, 2024 | Loop Capital Markets | Buy | Buy | Hold |
| Aug 12, 2024 | Citigroup | - | Buy | Initialise |
| Aug 12, 2024 | RBC Capital | - | Outperform | Initialise |
| Aug 12, 2024 | Morgan Stanley | - | Overweight | Initialise |
Ardent Health Partners's last stock rating was published by Bank of America Securities on Nov 06, 2024. The company Downgrade its ARDT rating from "null" to "Neutral".
Ardent Health Partners Financial Forecast
Ardent Health Partners Revenue Forecast
| Revenue |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| # Analysts |
| Surprise % |
Ardent Health Partners's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. ARDT's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Ardent Health Partners EBITDA Forecast
| # Analysts |
| EBITDA |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
undefined analysts predict ARDT's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Ardent Health Partners's previous annual EBITDA (undefined) of $NaN.
Ardent Health Partners Net Income Forecast
| # Analysts |
| Net Income |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
Ardent Health Partners's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ARDT's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Ardent Health Partners SG&A Forecast
| # Analysts |
| SG&A |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
Ardent Health Partners's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to ARDT last annual SG&A of $NaN (undefined).
Ardent Health Partners EPS Forecast
| # Analysts |
| EPS |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
According to undefined Wall Street analysts, Ardent Health Partners's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ARDT previous annual EPS of $NaN (undefined).